Several macrolide-, lincosamide-, and streptogramin B-type (MLS) antibiotics were tested as inducers of erythromycin A (EM)-resistant [14C]leucine incorporation. Only 14-membered-ring macrolides having a glycosidically linked 6-deoxy sugar at the C-3 position of the lactone ring and the structurally dissimilar lincosamide, celesticetin, showed inducer activity. Modifications of EM at the C-4" position of cladinose can apparently destroy the inducer property but do not affect the inhibitory properties of the antibiotic. The findings clearly show that inducer and inhibitor activities can be dissociated and are consistent with the concept that distinct binding/receptor sites are utilized for inhibition of ribosome function and induction of resistance.
Macrolide resistance in certain strains of Staphylococcus aureus can be induced by exposure to subinhibitory concentrations of erythromycin A (EM) (1, 19) . Several antibiotics besides EM reportedly induce macrolide resistance in S. aureus. For example, oleandomycin (7, 8) , lankamycin (7) , desacetyllankamycin (7), leucomycin (11) , carbomycin (14) , and lincomycin (14) have been reported to induce resistance in strains isolated from diverse sources. Among clinical isolates, published descriptions of inducibly resistant S. aureus indicate only EM, oleandomycin, the lankamycins, and megalomycin as inducers of macrolide resistance (5, (7) (8) (9) 18) . These compounds are all 14-membered-ring macrolide antibiotics. In contrast, mutants of clinical strains that can be induced by diverse MLS antibiotics, including 14-and 16-membered-ring macrolides (11) and lincomycin (14) , have been isolated in the laboratory. One mutant is described as inducible by high temperature (13) . Apparently, both strain and drug specificities are determining factors in the induction of macrolide resistance.
EM and its derivatives are the only reported inducers of macrolide resistance in S. aureus 1206 (16, 19) . It was recently reported (14) that a mutant of this strain had lost EM inducibility but could be induced by either lincomycin or carbomycin. This report, coupled with the observation that celesticetin and several macrolides other than EM induced zone distortion when placed adjacent to lincomycin (1) , sug 
MATERIALS AND METHODS
The inductive capacity of MLS antibiotics was measured by growing S. aureus 1206 to early stationary phase in synthetic broth as described (1) . Cells were washed once and resuspended in fresh broth to a cell density of approximately 0.24 mg of protein per ml. After preincubation at 370C for 30 min, inducers were added at the desired concentration. Incubation of the cell suspension was continued for 2 h, and [14C]leucine incorporation in the presence and absence of 140 ,uM EM was measured on duplicate aliquots exactly as described before (1) . Each of the antibiotics tested for inducer activity was also assayed for inhibition of [14Clleucine incorporation as described (1), using cells incubated for 2 h without added antibiotics.
Sources of the antibiotics used have been cited previously (1) , and EM derivatives were kindly furnished by E. Massey of the Lilly Research Laboratories. Antibiotic stock solutions were routinely prepared in methanol-water at 1 to 5 mg/ml. The maximum level of methanol present during induction was 0.1%, and there was no inhibition of [14C]leucine incorporation or induction by methanol at this concentration. The EM derivatives were generally less soluble than the other antibiotics and were dissolved in undiluted methanol. Equivalent amounts of methanol were added to the untreated controls.
( Table 1 The data in Table 1 were accumulated from five separate experiments. In each experiment, EM was tested as an inducer along with an uninduced control, and standard errors are included with these data. In the absence of exogenous inducer, EM-resistant incorporation was approximately 16% of the uninhibited rate. An increase in resistant incorporation above this level indicates induction by the given antibiotic.
Among the 14-membered-ring macrolides, Neither vernamycin Ba nor lincomycin induced resistance, but celesticetin, a derivative of lincomycin (6) , showed good inducer activity. Although not as active as an inducer as EM at 0.14 ,uM, celesticetin appeared to be a more effective inducer at higher concentrations since its ability to inhibit protein synthesis and thus induction was less than that of EM.
EM derivatives. Eighteen derivatives of EM were compared for inducer activit using the disk method (18) . The derivatives are listed in Table 2 and the structure of EM is given in Fig.   1 Work from other laboratories (8, 10, 12) has indirectly suggested that the inductive capacity of macrolide antibiotics may be due, in part, to the structure and position of the 6-deoxy sugars. The results from the present study support this idea and further suggest a critical role for the sugar attached at the C-3 position of the lactone ring, e.g., cladinose in EM (Fig. 1) Third, both lankamycin and desacetyllankamycin showed inducer activity, but the desacetyl form was a more active inducer than the acetylated antibiotic. Lankamycin is acetylated at the C-4" position of arcanose, which is the 6-deoxy sugar attached to the lactone ring at the C-3 position. Omura et al. (7) reported identical findings for these two antibiotics using another method to measure induction.
Fourth, using the disk method to detect inducer activity among EM derivatives, all but two compounds were strong inducers. The 4"-tosyl and 4"-mesyl derivatives of EM cyclic carbonate were unable to induce zone distortion. The tosylated derivative failed to induce EM-resistant [14C]leucine incorporation, whereas the unmodified cyclic carbonate was as active an inducer as EM (Table 2 ; 8). Furthermore, inhibition of protein synthesis by the cyclic carbonate was equal to or greater than that shown by EM. Since the 4"-tosyl cyclic carbonate retains inhibitory activity, it is clear that reduced transport cannot account for the reduction in inducer activity. Thus, the loss of inductive capacity can be attributed to the modification at the C-4" position of cladinose (see Fig. 1 ).
Other workers have shown that the monoglycosides of EM (minus cladinose or desosamine) and the aglycone (minus both sugars) were either inactive or had severely diminished inducer activity (8, 10, 12) . Moreover, Ono et al. (8) reported that introduction ofan acetyl group in the C-4" position of EM resulted in decreased inducer activity but had a negligible effect on antibacterial activity. Taken together, the data clearly indicate that inducer and inhibitor activities of EM can be dissociated.
Fifth, induction by leucomycin using the mutant described by Saito et al. (11) was affected by modification of mycarose at the C-4" position. Although leucomycin is a 16-membered-ring macrolide and the sugar arrangement is not the same as in EM, removal of mycarose or deacetylation at the C-4" appeared to eliminate inducer activity.
Celesticetin's ability to induce macrolide resistance was unexpected since this antibiotic is structurally dissimilar to EM and other 14-membered-ring macrolides. Whether a structural similarity exists between celesticetin and EM analogous to the similarity between lincomycin and EM proposed to explain identical or related ribosome binding sites (16) remains to be determined. At any rate, induction by celesticetin means that inducibility in S. aureus is not limited to a narrow spectrum of closely related structural types and proves that induction of resistance in natural isolates of S. aureus is not strictly a property of macrolides. A closer similarity with inducibly macrolide-resistant streptococci, some of which can be induced by numerous MLS antibiotics (3, 4, 20) , is suggested. The fact that only MLS antibiotics will induce raises the interesting possibility that the binding or receptor site(s) on the hypothetical regulatory protein may recognize the same molecular structures as does the ribosomal binding site(s).
Tanaka and Weisblum (14) described a mutant of S. aureus that had lost EM inducibility but that could be induced by either lincomycin or carbomycin. They theorized that this phenotype may have resulted from a reversal of the relative potency these antibiotics had for inhibition and induction. In other words, other MLS antibiotics may be potential inducers, but fail because their capacity to inhibit is so much greater. The finding that celesticetin can induce resistance in S. aureus is consistent with this proposal, since although higher concentrations of this antibiotic are required for induction, celesticetin's capacity to inhibit ribosome function appears to be much less than that of EM. The inability of the 4"-tosyl cyclic carbonate of EM to induce resistance is further evidence that modification can alter the relative potency an antibiotic has for induction and inhibition.
Finally, clinically isolated inducibly macrolide-resistant staphylococci have been classified on the basis of whether they could be induced by EM only or by EM and oleandomycin (5, 8) . EM was previously reported as the only inducer in S. aureus 1206 (16) . It can be concluded from the studies reported here that numerous MLS antibiotics can potentially induce resistance but go undetected because they have a much stronger affinity for ribosome inhibition or because detection may require a sensitive measure of induction. The possibility that mutations can lead to a changed inducer spectrum coupled with the disclosure of inducible macrolide resistance in streptococci (3, 4, 20) warns that any classification of strains based solely on response to inducers would be an oversimplification at this time.
